Quick Answer
Krystal Biotech, Inc. reported Shares Outstanding of 29.19 million shares for fiscal year 2025.
Krystal Biotech, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 29.19M | +1.4% |
| 2024 | 28.79M | +2.0% |
| 2023 | 28.24M | +9.6% |
| 2022 | 25.76M | +2.2% |
| 2021 | 25.21M | +27.9% |
| 2020 | 19.71M | +13.6% |
| 2019 | 17.35M | +20.3% |
| 2018 | 14.43M | +40.0% |
| 2017 | 10.31M | +195.3% |
| 2017 | 3.49M | — |
| 2016 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 28.98M | +0.8% | +0.2% |
| June 30, 2025 | 28.93M | +0.8% | +0.1% |
| March 31, 2025 | 28.90M | +1.3% | +0.4% |
| December 31, 2024 | 28.79M | +2.0% | +0.1% |
| September 30, 2024 | 28.76M | +2.0% | +0.2% |
| June 30, 2024 | 28.71M | +2.6% | +0.6% |
| March 31, 2024 | 28.53M | +10.6% | +1.0% |
| December 31, 2023 | 28.24M | +9.6% | +0.2% |
- Krystal Biotech, Inc. showed an increase of +1.4% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: